InvestorsHub Logo
Followers 0
Posts 2
Boards Moderated 0
Alias Born 02/02/2020

Re: junkHustler post# 1547

Sunday, 02/02/2020 3:55:15 PM

Sunday, February 02, 2020 3:55:15 PM

Post# of 4862
I would be surprise to see a RS at this point. There will be roughly 400M shares outstanding when/if bophelo, hollywood dispensarie and canmart UK close. Add to that 150M warrants which 128M of them expire throughout 2020 if not executed. There could be more dilution coming with a California cultivation facility, joint venture with DNA Genetics/Eaze by example(this is just my 2 cents based on the extensive due dilligence amd knowledge of the sector).

There could be an other PP attached to an other dillutive deal soon but that should be the last. When Bophelo close, halo will be able to have non dillutive financing from a bank in leshoto(Nedbank by example) to finance all operations at a bargain interest rate if you compare that to other financing in the sector(convertible debentures/dillutive financing).

Take in considerstion mmen is at 550m+ share fully diluted, cura is at 780m+ shares fully diluted, cresco labs is at 400m+ shares fully diluted, harvest is at 480m+ shares fully diluted, cura is at 670m+ shares fully diluted, Acb is at 1.2B shares fully diluted, etc.

Halo is far from being Fsd pharma(huge) which reverse splitted back in fall.

By the way, I heard the last 100 Cali distro licences have been canceled by the govt and a new roll process would be done.

Canmart UK and hollywood distro dillution are based on certain milestones achieved.

I wouldn't be surprised to see hollywood deal canceled if the licence is held back.

People complain way to much on dillution in my opinion. They just don't see the whole picture.

One last thing; If you take a look at UK cannabis import standards, you will see that accudab from precisa medical acquisition fits pretty much the mold.

Happy investing all!